AI’s role in curing genetic disease, with Mammoth Biosciences (Trevor Martin)
YouTube
Opinion — commentary, not a factual news event.
Trevor Martin of Mammoth Biosciences describes how the company uses AI to search large protein spaces and engineer smaller CRISPR systems for genetic disease work. The discussion highlights the key proof hurdle: validating what actually survives contact with a human body. The result is a clearer focus on biological validation rather than AI alone solving everything.
Why it matters
Dr. Trevor Martin (co-founder of Mammoth Biosciences) lays out how the company uses AI to search huge protein spaces and engineer smaller CRISPR systems. The discussion separates the real bottlenecks from the sci-fi ones—especially the challenge of proving what survives contact with an actual human body.